High on-treatment platelet reactivity in transcatheter aortic valve implantation patients

European Journal of Pharmacology

Volumn 751, Issue , 2015, Pages 24-27

  Polzin, Amin ^a,b   Schleicher, Mathias ^a   Seidel, Holger ^a   Scharf, Rüdiger E ^a   Merx, Marc W ^a   Kelm, Malte ^a   Zeus, Tobias ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Pneumologie und Angiologie   (Germany)

Author keywords

HTPR; TAVI

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COMPLICATION; DRUG EFFECT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HIGH ON TREATMENT PLATELET REACTIVITY; HUMAN; INCIDENCE; ISCHEMIA; LOW ON TREATMENT PLATELET REACTIVITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PLATELET REACTIVITY; THROMBOCYTE FUNCTION ANALYZER; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; THROMBOCYTE;

AGED; ASPIRIN; BLOOD PLATELETS; FEMALE; HUMANS; ISCHEMIA; MALE; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84922644060     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.01.028     Document Type: Article

References (18)

1. O. Ait-Mokhtar, L. Bonello, S. Benamara, and F. Paganelli High on treatment platelet reactivity Heart Lung Circ. 21 2012 12 21
2. T. Garabedian, and S. Alam High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistance Cardiovasc. Diagn. Ther. 3 2013 23 37
3. A.M. Gori, R. Marcucci, A. Migliorini, R. Valenti, G. Moschi, R. Paniccia, and D. Antoniucci Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents J. Am. Coll. Cardiol. 52 2008 734 739
4. P.A. Gurbel, R.C. Becker, K.G. Mann, S.R. Steinhubl, and A.D. Michelson Platelet function monitoring in patients with coronary artery disease J. Am. Coll. Cardiol. 50 2007 1822 1834
5. W. Hochholzer, D. Trenk, M.F. Fromm, C.M. Valina, C. Stratz, H.P. Bestehorn, and F.J. Neumann Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement J. Am. Coll. Cardiol. 55 2010 2427 2434
6. T. Hohlfeld, A. Saxena, and K. Schror High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs - pharmacological mechanisms and clinical relevance Thromb. Haemost. 109 2013 825 833
7. A. Polzin, T. Zeus, K. Schror, M. Kelm, and T. Hohlfeld Dipyrone (metamizole) can nullify the antiplatelet effect of aspirin in patients with coronary artery disease J. Am. Coll. Cardiol. 6218 2013 1725 1726
8. J.J. Rade Platelet function testing in patients with coronary artery disease: is the who and the when any clearer than the what and the what then? Circulation 125 2012 3073 3075
9. D.I. Roberts, and J.J. Nawarskas Treatment options for patients with poor clopidogrel response Cardiol. Rev. 21 2013 309 317
10. J. Rodes-Cabau, H.L. Dauerman, M.G. Cohen, R. Mehran, E.M. Small, S.S. Smyth, and R.C. Becker Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events J. Am. Coll. Cardiol. 62 2013 2349 2359
11. K. Schror, K. Huber, and T. Hohlfeld Functional testing methods for the antiplatelet effects of aspirin Biomark. Med. 5 2011 31 42
12. J. Silvain, G. Cayla, J.S. Hulot, J. Finzi, M. Kerneis, S.A. O'Connor, and G. Montalescot High on-thienopyridine platelet reactivity in elderly coronary patients: the senior-platelet study Eur. Heart J. 33 2012 1241 1249
13. E. Stabile, A. Pucciarelli, L. Cota, G. Sorropago, T. Tesorio, L. Salemme, and P. Rubino SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation Int. J. Cardiol. 174 2014 624 627
14. U.S. Tantry, L. Bonello, D. Aradi, M.J. Price, Y.H. Jeong, D.J. Angiolillo, and P.A. Gurbel Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding J. Am. Coll. Cardiol. 62 2013 2261 2273
15. G.P. Ussia, M. Scarabelli, M. Mule, M. Barbanti, K. Sarkar, V. Cammalleri, and C. Tamburino Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation Am. J. Cardiol. 108 2011 1772 1776
16. A. Vahanian, O. Alfieri, F. Andreotti, M.J. Antunes, G. Baron-Esquivias, H. Baumgartner, and M. Zembala Guidelines on the management of valvular heart disease (version 2012) Eur. Heart J. 33 2012 2451 2496
17. T. Walther, P. Simon, T. Dewey, G. Wimmer-Greinecker, V. Falk, M.T. Kasimir, and M. Mack Transapical minimally invasive aortic valve implantation: multicenter experience Circulation 116 2007 I240 I245
18. J.G. Webb, S. Pasupati, K. Humphries, C. Thompson, L. Altwegg, R. Moss, and S.V. Lichtenstein Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis Circulation 116 2007 755 763